Trial intelligence / Profile preview

Large vs Small Volume Bupivacaine in Elective Caesarean Section

NCT02937792Unknown

Sponsor
Cairo University
Start
Oct 2016
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in caesarean section (CS) (2 arms), sponsored by Cairo University. Primary endpoint: Vital signs at 45 minutes. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

caesarean section (CS)

Beyond the preview

Go deeper on NCT02937792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02937792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call